menu
    • menu

    Company profile for Viriom

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    Smithfield BioScience transforms bioproducts into trusted, life-saving therapies through safe, reliable U.S.-based manufacturing.

    Virtual Booth

    Contact Supplier

    Quotient Sciences- Molecule to Cure. Fast.

    Virtual Booth

    Contact Supplier

    SWATI - Transforming science into solutions with 60+ years of expertise, global accreditations, and pioneering biotech innovation.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Viriom focuses on the treatment, prophylaxis, and eradication of infectious diseases globally. Viriom is developing and commercializing the most innovative and affordable solutions to radically expand global access to the best antiviral treatments. Viriom's broad, proprietary, and partnered pipeline covers therapeutic, prophylactic, and curative medicines for HIV, viral hepatitis, flu coronaviruses and other pathogenic infecti...
    Viriom focuses on the treatment, prophylaxis, and eradication of infectious diseases globally. Viriom is developing and commercializing the most innovative and affordable solutions to radically expand global access to the best antiviral treatments. Viriom's broad, proprietary, and partnered pipeline covers therapeutic, prophylactic, and curative medicines for HIV, viral hepatitis, flu coronaviruses and other pathogenic infectious diseases.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    ViriomUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    12760 High Bluff Drive, Suite 370 San Diego CA 92130
    Telephone
    Telephone
    (858) 794-4860
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.viriom.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Tides Asia

    Tides Asia

    Not Confirmed

    envelop Contact Supplier

    Tides Asia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Viriom and Chromis publish results of a multi-center open label post-marketing
    Viriom and Chromis publish results of a multi-center open label post-marketing

    10 Mar 2021

    // PRNEWSWIRE

    https://www.prnewswire.com/news-releases/viriom-and-chromis-publish-results-of-a-multi-center-open-label-post-marketing-clinical-study-in-940-covid-19-patients-confirming-efficacy-of-avifavir-at-croi2021-301243948.html

    PRNEWSWIRE
    10 Mar 2021
    Share Share
    Viriom, Chromis’ Avifavir reduces time to virus elimination in Covid-19 patients
    Viriom, Chromis’ Avifavir reduces time to virus elimination in Covid-19 patients

    09 Mar 2021

    // PHARMACEUTICAL-TECHNOLOGY

    https://www.pharmaceutical-technology.com/news/viriom-avifavir-virus-elimination/

    PHARMACEUTICAL-TECHNOLOGY
    09 Mar 2021
    Share Share
    Elpida (elsulfavirine) becomes the preferred first line therapy for treatment
    Elpida (elsulfavirine) becomes the preferred first line therapy for treatment

    02 Feb 2021

    // PRNEWSWIRE

    https://www.prnewswire.com/news-releases/elpida-elsulfavirine-becomes-the-preferred-first-line-therapy-for-treatment-of-hiv-infection-in-russia-301220399.html

    PRNEWSWIRE
    02 Feb 2021
    Share Share
    Viriom initiates ph2 study of intramuscular injectable nanoformulation VM1500A
    Viriom initiates ph2 study of intramuscular injectable nanoformulation VM1500A

    05 May 2020

    // PHARMABIZ

    http://www.pharmabiz.com/NewsDetails.aspx?aid=123918&sid=2

    PHARMABIZ
    05 May 2020
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search